Company intelligence / Profile preview

Hennepin Life Sciences

Plymouth, Minnesota, United States

Ownership: Private
Employees: ~2
Development stage: Other

Overview

Hennepin Life Sciences is developing naturally-derived, broad-spectrum antimicrobials with in vitro and pre-clinical evidence of efficacy against bacterial and fungal infections, with particular IP strength and partnership for women's health applications (licensed out to Daré Bioscience).

Therapeutic areas: Infectious DiseasesWomen's Health
Modalities: Small moleculeAntimicrobial compound
Industry: Biotech

Partnerships

Daré Bioscience

Beyond the preview

Go deeper on Hennepin Life Sciences.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hennepin Life Sciences.

Explore the full profile